Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin J Churchyard

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|June 5, 2007
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BChristopher J Hoffmann, Salome Charalambous, Chloe L Thio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, John Sim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Preventing multidrug resistant tuberculosis: the dawn of a new eraGavin J Churchyard, Susan Swindells, Amita Gupta, et al.
AIDS (London, England)|December 20, 2007
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical eventsChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
International Journal of STD & AIDS|October 10, 2013
The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participantsJonathan E Volk, Nancy A Hessol, Glenda E Gray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2011
Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosisCeline R Gounder, Tendesayi Kufa, Nikolas I Wada, et al.
The Lancet. HIV|November 16, 2019
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trialAlison D Grant, Salome Charalambous, Mpho Tlali, et al.
The New England Journal of Medicine|January 24, 2014
A trial of mass isoniazid preventive therapy for tuberculosis controlGavin J Churchyard, Katherine L Fielding, James J Lewis, et al.
The American Journal of Tropical Medicine and Hygiene|October 18, 2021
Causes and Outcomes of Admission and Investigation of Tuberculosis in Adults with Advanced HIV in South African Hospitals: Data from the TB Fast Track TrialPeter G Beckwith, Mpho Tlali, Salome Charalambous, et al.
Journal of Clinical Microbiology|January 13, 2012
Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South AfricaSusan E Dorman, Violet N Chihota, James J Lewis, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|June 5, 2007
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BChristopher J Hoffmann, Salome Charalambous, Chloe L Thio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, John Sim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Preventing multidrug resistant tuberculosis: the dawn of a new eraGavin J Churchyard, Susan Swindells, Amita Gupta, et al.
AIDS (London, England)|December 20, 2007
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical eventsChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
International Journal of STD & AIDS|October 10, 2013
The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participantsJonathan E Volk, Nancy A Hessol, Glenda E Gray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2011
Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosisCeline R Gounder, Tendesayi Kufa, Nikolas I Wada, et al.
The Lancet. HIV|November 16, 2019
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trialAlison D Grant, Salome Charalambous, Mpho Tlali, et al.
The New England Journal of Medicine|January 24, 2014
A trial of mass isoniazid preventive therapy for tuberculosis controlGavin J Churchyard, Katherine L Fielding, James J Lewis, et al.
The American Journal of Tropical Medicine and Hygiene|October 18, 2021
Causes and Outcomes of Admission and Investigation of Tuberculosis in Adults with Advanced HIV in South African Hospitals: Data from the TB Fast Track TrialPeter G Beckwith, Mpho Tlali, Salome Charalambous, et al.
Journal of Clinical Microbiology|January 13, 2012
Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South AfricaSusan E Dorman, Violet N Chihota, James J Lewis, et al.
Pageof 14